Broderick Turner

Statistics

Publications

Citations

117

H-Index

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Rice University

Broderick Turner is an author at The University of Texas MD Anderson Cancer Center specializing in clonogenic survival assays, dna repair, and radiation therapy.

ORCID

Publications per year

2020–2024

Publications

A Novel Resistance Pathway for Calcineurin Inhibitors in the Human-Pathogenic Mucorales Mucor circinelloides

Sandeep Vellanki, R. Blake Billmyre, Alejandra Lorenzen et al. · mBio · 2020 · 46 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons

Scott J. Bright, David B. Flint, David Martinus et al. · Radiation Research · 2022 · 20 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Cell lines of the same anatomic site and histologic type show large variability in intrinsic radiosensitivity and relative biological effectiveness to protons and carbon ions

David B. Flint, Scott J. Bright, Conor H. McFadden et al. · Medical Physics · 2021 · 18 citations · Full text

Medicine, Oncology, Radiation Oncology +17

An empirical model of proton RBE based on the linear correlation between x‐ray and proton radiosensitivity

David B. Flint, Chase E. Ruff, Scott J. Bright et al. · Medical Physics · 2022 · 18 citations · Full text

Medicine, Biophysics, Radiation Oncology +17

ATR inhibition radiosensitizes cells through augmented DNA damage and G2 cell cycle arrest abrogation

Scott J. Bright, Mandira Manandhar, David B. Flint et al. · JCI Insight · 2024 · 15 citations · Full text

Medicine, Oncology, Radiation Oncology +16

1–5 of 5